NASDAQ: $TXG
10x Genomics, Inc., a prominent innovator in the fields of single cell and spatial biology, has confirmed its participation in a significant industry event next month. The company announced that key members of its management team are slated to present at the highly anticipated 46th Annual TD Cowen Health Care Conference.
The scheduled presentation will take the format of a fireside chat, providing an opportunity for investors and industry observers to gain insights into the company’s recent progress, strategic direction, and the impact of its platform technologies on biological research and therapeutic development. The session is set for Tuesday, March 3, at 11:50 a.m. Eastern Time.
For those unable to attend the conference in person or wishing to follow the presentation remotely, 10x Genomics has made arrangements for a live webcast. Interested parties can access the webcast directly through the dedicated “Investors” section of the official company website. The specific link for access is provided as: https://investors.10xgenomics.com/.
In a commitment to accessibility, the company further specified that the webcast will not be a fleeting opportunity. Following the live event, the recording of the fireside chat will be archived and made available for replay on the investor relations portal for a minimum period of 30 days. This ensures that analysts, shareholders, and potential partners worldwide have ample time to review the management’s discussion concerning 10x Genomics’ standing and future prospects in the rapidly evolving landscape of advanced biological analysis.
Participation in premier conferences like the TD Cowen Health Care Conference underscores 10x Genomics’ commitment to transparent communication with the financial community regarding its pioneering work in providing comprehensive views of biological systems through cutting-edge instrumentation and assays.